Read the latest press releases for 4D pharma plc.
Click on a news title to read full details. For Regulatory News Service (RNS) announcements please click here.
8 Nov 2018, 12:00
4D pharma plc announces first patient enrolment in Blautix IBS Phase II study
24 Sep 2018, 12:00
4D pharma plc (AIM: DDDD), announces positive top-line results for its Phase Ib study of Thetanix in…
14 Aug 2018, 09:00
Data suggests that MRx0004 is a promising next-generation therapeutic for management of asthma
30 Jul 2018, 08:32
30 July 2018 -- 4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live…
27 Jun 2018, 08:35
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
13 Jun 2018, 08:37
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
7 Jun 2018, 08:38
4D pharma plc (AIM: DDDD), a clinical stage biopharmaceutical company, pioneering the development of…
4 Jun 2018, 11:45
4D pharma will present at the 2nd Annual Microbiome Discovery & Development Congress which takes…
4 Jun 2018, 08:44
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
21 May 2018, 08:47
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
10 May 2018, 12:49
4D pharma will participate in the Global Engage Microbiome Futures Conference in New York on May…
8 May 2018, 08:49
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics,…
23 Apr 2018, 08:51
4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of live…
21 Mar 2018, 08:52
4D pharma plc (AIM: DDDD), a pharmaceutical company focusing on the development of live…
12 Feb 2018, 12:56
4D pharma will present preclinical data on its immuno-oncology programme at the Cell-Weizmann…
